SARS_CoV_2 mutation literature information.


  Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.
 PMID: 34419160       2021       Infectious diseases of poverty
Table: S494P


  Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2.
 PMID: 34452507       2021       Viruses
Result: At day 7, E484K was not detected by any of these tests, but a S494P, also described in several VOC, particularly under selection by immunoglobulins, was detected on the S gene.
Discussion: Finally, all six patients presented a mutation associated with resistance or suspicion of resistance in the Spike protein, including E484A/K, but also S494P and Q493R.


  Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies.
 PMID: 34484190       2021       Frontiers in immunology
Figure: Eight mutations (Y453F, L455F, F456L, A475V, A475S, T500S, N501Y, and Y505H) were in the RBD and hACE2 interaction region (RBD/hACE2); 10 mutations (V367I, V382L, R408G, N438K, L452Q, S477N, T478K, E484Q, S494P, and A520S) were in the RBD region but no


  Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization.
 PMID: 32699850       2020       bioRxiv
Result: These include N439K in 246 samples (244 Scottish, 1 England, 1 Romania), V483A in 30 samples (26 USA/WA, 2 USA/UN, 1 USA/CT, 1 England), G476S in 18 samples (13 USA/WA, 2 USA/OR, 1 USA/ID, 1 USA/CT, 1 Belgium), S494P in 7 samples (3 USA/MI, 1 England, 1 Spain, 1 India, 1 Sweden), V483I in 2 English samples, and L455I together with F456V in one Brazilian sample.



Browser Board

 Co-occurred Entities




   Filtrator